Citation: T. Carlsson et al., Hepatitis C virus kinetics during induction and standard 3 times a week interferon-alpha therapy, SC J IN DIS, 33(11), 2001, pp. 838-842
Authors:
Sennfalt, K
Reichard, O
Hultkrantz, R
Wong, JB
Jonsson, D
Citation: K. Sennfalt et al., Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for chronic hepatitis C in Sweden, SC J GASTR, 36(8), 2001, pp. 870-876
Authors:
Carlsson, T
Lindahl, K
Schvarcz, R
Wejstal, R
Uhnoo, I
Shev, S
Reichard, O
Citation: T. Carlsson et al., HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirin, J VIRAL HEP, 7(6), 2000, pp. 409-413
Authors:
Schvarcz, R
Glaumann, H
Reichard, O
Weiland, O
Citation: R. Schvarcz et al., Histological and virological long-term outcome in patients treated with interferon-alpha 2b and ribavirin for chronic hepatitis C, J VIRAL HEP, 6(3), 1999, pp. 237-242
Authors:
Reichard, O
Glaumann, H
Fryden, A
Norkrans, G
Wejstal, R
Weiland, O
Citation: O. Reichard et al., Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon, J HEPATOL, 30(5), 1999, pp. 783-787
Authors:
Weiland, O
Braconier, JH
Fryden, A
Norkrans, G
Reichard, O
Uhnoo, I
Citation: O. Weiland et al., Influence of pre-treatment factors on outcome of interferon-alpha treatment of patients with chronic hepatitis C, SC J IN DIS, 31(2), 1999, pp. 115-118
Authors:
Reichard, O
Norkrans, G
Fryden, A
Braconier, JH
Sonnerborg, A
Weiland, O
Citation: O. Reichard et al., Comparison of 3 quantitative HCV RNA assays - Accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C, SC J IN DIS, 30(5), 1998, pp. 441-446